Molecular Diagnostics Market Boosted by Automation and Digitization to Streamline Inspection by Forecast to 2030

Comments ยท 2 Views

The Molecular Diagnostics Market is Segmented by Technology (In Situ Hybridization, Chips and Microarrays, Mass Spectrometry (MS), Sequencing, PCR, and Other Technologies), Application (Infectious Disease, Oncology, Pharmacogenomics, Microbiology, and Genetic Disease Screening, Human Leuko

Molecular Diagnostics Market Report 2024 by Delvens offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance, the global molecular diagnostics market was valued at USD 9,371 million in 2020, and it is expected to reach 15,196 million by 2026, registering a CAGR of 10.2% during the forecast period.

Get Free Sample Report: https://www.delvens.com/get-free-sample/molecular-diagnostics-market

Key Players of Molecular Diagnostics Market

·        Abbott Laboratories

·        F Hoffmann-la Roche Ltd

·        Hologic Corporation

·        Danaher Corporation

·        Agilent Technology and More

As per the scope of the report, molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphisms (SNP), deletions, rearrangements, insertions, and others), which may or may not be associated with diseases. Molecular diagnostics has been revolutionized over the past few decades.

Recent Developments

January 2020, Illumina received product approval from Pharmaceuticals and Medical Devices Agency (PMDA), Japan for MiSeqDx instrument. This approval allows for the distribution of the MiSeqDx as a Class I medical device in Japan, which shows a positive impact on the market.

July 2020, Roche Diagnostics India launched the Cobas 8800 instrument at the National Institute of Cholera and Enteric Diseases, Kolkata, and Cobas 6800 at the National Institute for Research in Reproductive Health, Mumbai, to aid with SARS CoV-2 diagnostic testing. Roche’s Cobas 6800/8800 systems provide test results in three and half hours and offer improved operating efficiency, flexibility, and fastest time-to-time results.

For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/molecular-diagnostics-market

Regional Analysis

In 2020, North America accounted for the largest share of the global molecular diagnostics market. The North American molecular diagnostics market's growth can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.

The Report helps to identify the opportunities in Global Regions:

·        North America (the United States, Canada, and Mexico)

·        Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)

·        Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))

·        South America (Brazil etc.)

·        The Middle East and Africa (North Africa and GCC Countries)

Molecular Diagnostics Market is segmented into technology, application, product, end user and region.

On the basis of Technology

·        In situ hybridization

·        Chips and microarrays

·        Mass spectrometry (MS)

·        Sequencing

·        PCR

On the basis of Application 

·        Infectious disease

·        Oncology

·        Pharmacogenomics

·        Genetic disease screening

·        Human leukocyte antigen typing

·        Blood screening

On the basis of Product 

·        Instruments

·        Reagents

On the basis of End-User

·        Hospitals

·        Laboratories

Access More Report: https://www.delvens.com/report/molecular-diagnostics-market

In addition to the market data for Molecular Diagnostics Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

More Related Reports:

Cannabidiol Market

Electronic Trial Master File (ETMF) Market

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com

Comments